Nebenwirkungen · NovoSeven
NovoSeven 1 mg (50 KIU) powder and solvent for solution for injection NovoSeven 2 mg (100 KIU) powder and solvent for solution for injection NovoSeven 5 mg (250 KIU) powder and solvent for solution for injection NovoSeven 8 mg (400 KIU) powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-085116 · Präparat HOS-083079
Vascular - Venous - Arterial thromboembolic - Intracardiac thrombus disorders thromboembolic events (myocardial events (deep vein infarction, cerebral thrombosis, infarction, cerebral thrombosis at i.v. site, ischaemia, cerebral pulmonary embolism, artery occlusion, thromboembolic cerebrovascular accident, events of the liver renal artery thrombosis, including portal vein peripheral ischaemia, thrombosis, renal vein peripheral arterial thrombosis, thrombosis and intestinal thrombophlebitis, ischaemia) superficial thrombophlebitis and - Angina pectoris intestinal ischaemia)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-01-05T10:11:00Z · SHA-256 4cde9b1f299068eba5f867a596fb73966c9f4132d6fc783820f32def35917cf3 · Passage 0a596110f984c0f8ea080c7c551cffbcdb0cabe6e3eefdd02b825e53f2475ec9 · Zeichen 3950–5074 im Abschnitt